top of page

March 2021 // Science

Updated: Oct 26, 2021

We are excited to share a scientific publication about the beneficial effect of the prototype SERI WOBE437 in a clinically relevant mouse model of Multiple Sclerosis and transient spasticity.

The article is published on ACS Pharmacology & Translational Science as the result of collaborative work between the group of Prof. J. Gertsch and Prof. B. Engelhardt at the University of Bern under the leadership of Dr. Andrea Chicca.

Find out more

Graphic: Reynoso-Moreno et al., 2021.

Recent Posts

See All

Synendos Therapeutics AG announces that co-founder and Scientific Advisor Board member, Professor Jürg Gertsch, presented groundbreaking new findings on an endocannabinoid transporter at the 10th Gord

Synendos Therapeutics is ranked TOP 100 Swiss Startups 2022 We are honored to be listed for the second year in a row as one of the TOP 100 Swiss Startups 2022. A big thank you to our team, partners, c

bottom of page